Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.55	0.55	0
Cash & Cash Equivalents	0.55	0.55	0
Cash Growth	-	12197.67%	-
Other Current Assets	0.7	0.7	0.29
Total Current Assets	1.25	1.25	0.3
Long-Term Investments	0.17	0.17	0.21
Goodwill and Intangibles	0.25	0.25	0.45
Other Long-Term Assets	0.07	0.07	0.07
Total Long-Term Assets	0.49	0.49	0.72
Total Assets	1.74	1.74	1.02
Accounts Payable	1.27	1.27	1.39
Current Debt	0.06	0.06	0.11
Other Current Liabilities	9.72	9.72	7.86
Total Current Liabilities	11.05	11.05	9.35
Long-Term Debt	2.63	2.63	1.2
Other Long-Term Liabilities	4.92	4.92	4.38
Total Long-Term Liabilities	7.55	7.55	5.58
Total Liabilities	18.6	18.6	14.93
Total Debt	2.68	2.68	1.31
Debt Growth	-	105.30%	-
Retained Earnings	-86.32	-86.32	-77.48
Comprehensive Income	-0.12	-0.12	-0.09
Shareholders' Equity	-19.79	-19.79	-16.85
Net Cash / Debt	-2.13	-2.13	-1.3
Working Capital	-9.8	-9.8	-9.06

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).